Literature DB >> 26961461

Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment.

Antonio Granata1, Anna Clementi2, Grazia Maria Virzì3, Alessandra Brocca4, Massimo de Cal3, Viviana Rosalia Scarfia1, Luca Zanoli5, Claudio Ronco3, Salvatore Corrao6, Lorenzo Malatino7.   

Abstract

Cardiorenal syndrome type 4 (CRS type 4), or chronic renocardiac syndrome, has been defined as "chronic abnormalities in renal function leading to cardiac disease" and recognizes the extreme burden of cardiovascular disease (CVD) risk in patients with chronic kidney disease (CKD). CKD is common and increasingly recognized as a risk factor for CVD. Even though the treatment for CVD has dramatically improved over the past decades, it still takes responsibility for up to 50% of deaths in CKD patients. For this reason, patients with CKD should be thoroughly evaluated for cardiovascular risk factors that require careful management, given the significant burden of CRS type 4 on the healthcare system. This review focuses on the most significant conventional and non-conventional CVD risk factors related to CKD.
Copyright © 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cardiorenal syndrome type 4; Cardiovascular risk; Chronic kidney disease; Hypertension; Left ventricular hypertrophy

Mesh:

Year:  2016        PMID: 26961461     DOI: 10.1016/j.ejim.2016.02.019

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

Review 1.  Arterial Stiffness in the Heart Disease of CKD.

Authors:  Luca Zanoli; Paolo Lentini; Marie Briet; Pietro Castellino; Andrew A House; Gerard M London; Lorenzo Malatino; Peter A McCullough; Dimitri P Mikhailidis; Pierre Boutouyrie
Journal:  J Am Soc Nephrol       Date:  2019-04-30       Impact factor: 10.121

Review 2.  Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.

Authors:  Nigar Sekercioglu; Lehana Thabane; Juan Pablo Díaz Martínez; Gihad Nesrallah; Christopher J Longo; Jason W Busse; Noori Akhtar-Danesh; Arnav Agarwal; Reem Al-Khalifah; Alfonso Iorio; Gordon H Guyatt
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

3.  Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore.

Authors:  Palvinder Kaur; Nakul Saxena; Alex Xiaobin You; Raymond C C Wong; Choon Pin Lim; Seet Yoong Loh; Pradeep Paul George
Journal:  BMJ Open       Date:  2018-05-20       Impact factor: 2.692

4.  Stem Cell-Derived, microRNA-Carrying Extracellular Vesicles: A Novel Approach to Interfering with Mesangial Cell Collagen Production in a Hyperglycaemic Setting.

Authors:  Sara Gallo; Maddalena Gili; Giusy Lombardo; Alberto Rossetti; Arturo Rosso; Patrizia Dentelli; Gabriele Togliatto; Maria Chiara Deregibus; Daniela Taverna; Giovanni Camussi; Maria Felice Brizzi
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

5.  Synergistic effect of renalase and chronic kidney disease on endothelin-1 in patients with coronary artery disease ‒ a cross-sectional study.

Authors:  Yu-Hsuan Li; Wayne Huey-Herng Sheu; Wen-Jane Lee; Jun -Sing Wang; Chia-Po Fu; Kae-Woei Liang; I-Te Lee
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

6.  Sonographic Venous Velocity Index Identifies Patients with Chronic Kidney Disease and Severe Diastolic Dysfunction.

Authors:  Markus Meier; Wolfram Johannes Jabs; Maria Guthmann; Gesa Geppert; Ali Aydin; Martin Nitschke
Journal:  Ultrasound Int Open       Date:  2018-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.